Fighting BRCA Linked Cancer – PARP Inhibition
A recent Institute of Cancer Research study published in the New England Journal of Medicine describes a novel way of treating BRCA-gene based cancers. Mutations in the BRCA-1 and BRCA-2 genes are routinely linked with higher incidence of breast and ovarian cancers in women; however, in healthy cells, the aforementioned…